#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myxofibrosarcoma Palmoplantar pustulosis IPEX syndrome Oesophageal atresia Breast angiosarcoma metastatic Infantile apnoea Duchenne muscular dystrophy gene carrier Fibrous dysplasia of bone Prolymphocytic leukaemia Chronic cutaneous lupus erythematosus Candida infection Prophylaxis against transplant rejection Pericarditis Idiopathic inflammatory myopathy Immunodeficiency common variable More trials…

    Learn about Rare Diseases

    Glycogen storage disease type II – Basic Information Mucopolysaccharidosis II Mucopolysaccharidosis III – Trials in Disease Loeys-Dietz syndrome – Life with Disease Cystic fibrosis – Trials in Disease Angelman’s syndrome – Trials in Disease Osteosarcoma recurrent – Trials in Disease Myxofibrosarcoma – Basic Information Angiosarcoma – Trials in Disease Waldenstrom’s macroglobulinaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Temocillin Bi 764532 DNL593 Acetylcholine Chloride TUB-030 Bictegravir Reparixin Ladarixin Meropenem Anhydrous Wt1 Lamp Mrna Dc Nefopam Ralinepag Prasugrel Hydrobromide Islatravir Specific Nucleic Acid Sna-Ebv Nizaracianine Triflutate Glipizide Paclitaxel Obaluronate Bilastine Oxitriptan More therapies…

    Learn about Your Condition

    Organ donor Naevus flammeus Prodromal Alzheimer's disease Thrombosis Neurodermatitis Pancoast's tumour Microscopic polyangiitis Ataxia telangiectasia Supranuclear palsy Nephrogenic anaemia Turner's syndrome Neuroendocrine tumour Colour blindness Vulvar dysplasia Post-traumatic stress disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A Study of Enlicitide for Safety and Effectiveness in Children and Adolescents with Heterozygous Familial Hypercholesterolemia

    Recruiting

    4 1
    Investigated Diseases:
    • Type IIa hyperlipidaemia
    Investigated Drugs:
    • Enlicitide Chloride
    Belgium Czechia Finland France Germany Italy +4

  • Study of K1-70 compared to placebo for patients with active thyroid eye disease from Graves’ disease

    Recruiting

    2 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • HUMAN IGG1 MONOCLONAL ANTIBODY AGAINST THYROTROPIN RECEPTOR
    Italy Spain

  • Testing bifikafusp alfa, onfekafusp alfa, and pembrolizumab combination in patients with advanced melanoma that did not respond to previous immunotherapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Bifikafusp Alfa
    • Onfekafusp Alfa
    • Pembrolizumab
    Germany Italy

  • A study testing BNT326 and BNT327 with drug combination for safety and effectiveness in people with advanced non-small cell lung cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • HER2 mutant non-small cell lung cancer
    • Non-small cell lung cancer recurrent
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pemetrexed Disodium
    • BNT327
    • Carboplatin
    Germany Italy Poland Spain

  • A Study of Cannabidiol for Sleep Quality After Evening Exercise in Healthy People

    Recruiting

    2 1
    Investigated Drugs:
    • Cannabidiol
    • SOFTISAN 378
    Belgium

  • A study testing the safety and effectiveness of infigratinib compared to placebo in infants and young children with achondroplasia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Investigated Drugs:
    • Infigratinib
    Norway Spain
Previous Page
1 … 66 67 68 69 70 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!